Regulation of miR106b cluster through the RB pathway

References

• Knudsen ES, Knudsen KE. Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer 2008; 8:714 - 24; http://dx.doi.org/10.1038/nrc2401; PMID: 19143056
   PubMed Web of Science ®Google Scholar
• Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8:671 - 82; http://dx.doi.org/10.1038/nrc2399; PMID: 18650841
   PubMed Web of Science ®Google Scholar
• Goodrich DW. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 2006; 25:5233 - 43; http://dx.doi.org/10.1038/sj.onc.1209616; PMID: 16936742
   PubMed Web of Science ®Google Scholar
• Mittnacht S. Control of pRB phosphorylation. Curr Opin Genet Dev 1998; 8:21 - 7; http://dx.doi.org/10.1016/S0959-437X(98)80057-9; PMID: 9529601
   PubMed Web of Science ®Google Scholar
• Wang JY, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv Cancer Res 1994; 64:25 - 85; http://dx.doi.org/10.1016/S0065-230X(08)60834-9; PMID: 7879661
   PubMed Web of Science ®Google Scholar
• Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 2001; 21:4684 - 99; http://dx.doi.org/10.1128/MCB.21.14.4684-4699.2001; PMID: 11416145
   PubMed Web of Science ®Google Scholar
• Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, et al. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res 2002; 62:6587 - 97; PMID: 12438254
   PubMed Web of Science ®Google Scholar
• Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, et al. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J Biol Chem 2012; 287:7896 - 906; http://dx.doi.org/10.1074/jbc.M111.313759; PMID: 22262832
   PubMed Web of Science ®Google Scholar
• Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, et al. RB pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. Cell Cycle 2010; 9:4153 - 63; http://dx.doi.org/10.4161/cc.9.20.13454; PMID: 20948315
   PubMed Web of Science ®Google Scholar
• Herschkowitz JI, He X, Fan C, Perou CM. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas. Breast Cancer Res 2008; 10:R75; http://dx.doi.org/10.1186/bcr2142; PMID: 18782450
   PubMed Web of Science ®Google Scholar
• Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13:272 - 86; http://dx.doi.org/10.1016/j.ccr.2008.02.013; PMID: 18328430
   PubMed Web of Science ®Google Scholar
• Bao J, Li D, Wang L, Wu J, Hu Y, Wang Z, et al. MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. J Biol Chem 2012; 287:21686 - 98; http://dx.doi.org/10.1074/jbc.M111.328054; PMID: 22570483
   PubMed Web of Science ®Google Scholar
• Benhamed M, Herbig U, Ye T, Dejean A, Bischof O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat Cell Biol 2012; 14:266 - 75; http://dx.doi.org/10.1038/ncb2443; PMID: 22366686
   PubMed Web of Science ®Google Scholar
• Ofir M, Hacohen D, Ginsberg D. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 2011; 9:440 - 7; http://dx.doi.org/10.1158/1541-7786.MCR-10-0344; PMID: 21454377
   PubMed Web of Science ®Google Scholar
• Khoshnaw SM, Green AR, Powe DG, Ellis IO. MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 2009; 62:422 - 8; http://dx.doi.org/10.1136/jcp.2008.060681; PMID: 19398594
   PubMed Web of Science ®Google Scholar
• Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, et al. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012; In press http://dx.doi.org/10.1038/onc.2012.11; PMID: 22286770
   PubMed Web of Science ®Google Scholar
• Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007; 67:11612 - 20; http://dx.doi.org/10.1158/0008-5472.CAN-07-5019; PMID: 18089790
   PubMed Web of Science ®Google Scholar
• Liu S, Patel SH, Ginestier C, Ibarra I, Martin-Trevino R, Bai S, et al. MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet 2012; 8:e1002751; http://dx.doi.org/10.1371/journal.pgen.1002751; PMID: 22685420
   PubMed Web of Science ®Google Scholar
• Feng B, Dong TT, Wang LL, Zhou HM, Zhao HC, Dong F, et al. Colorectal cancer migration and invasion initiated by microRNA-106a. PLoS One 2012; 7:e43452; http://dx.doi.org/10.1371/journal.pone.0043452; PMID: 22912877
   PubMed Web of Science ®Google Scholar
• Knudsen ES, Wang JY. Targeting the RB pathway in cancer therapy. Clin Cancer Res 2010; 16:1094 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-09-0787; PMID: 20145169
   PubMed Web of Science ®Google Scholar
• Toogood PL, Harvey PJ, Repine JT, Sheehan DJ, VanderWel SN, Zhou H, et al. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. J Med Chem 2005; 48:2388 - 406; http://dx.doi.org/10.1021/jm049354h; PMID: 15801831
   PubMed Web of Science ®Google Scholar
• Dean JL, McClendon AK, Hickey TE, Butler LM, Tilley WD, Witkiewicz AK, et al. Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle 2012; 11:2756 - 61; http://dx.doi.org/10.4161/cc.21195; PMID: 22767154
   PubMed Web of Science ®Google Scholar
• Nana-Sinkam SP, Fabbri M, Croce CM. MicroRNAs in cancer: personalizing diagnosis and therapy. Ann N Y Acad Sci 2010; 1210:25 - 33; http://dx.doi.org/10.1111/j.1749-6632.2010.05822.x; PMID: 20973796
   PubMed Web of Science ®Google Scholar
• Ravi A, Gurtan AM, Kumar MS, Bhutkar A, Chin C, Lu V, et al. Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. Cancer Cell 2012; 21:848 - 55; http://dx.doi.org/10.1016/j.ccr.2012.04.037; PMID: 22698408
   PubMed Web of Science ®Google Scholar
• Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis 2012; 33:1126 - 33; http://dx.doi.org/10.1093/carcin/bgs140; PMID: 22491715
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010; 3:ra29; http://dx.doi.org/10.1126/scisignal.2000594; PMID: 20388916
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, et al. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 2012; 7:e32230; http://dx.doi.org/10.1371/journal.pone.0032230; PMID: 22393390
   PubMed Web of Science ®Google Scholar
• Li Z, Yang CS, Nakashima K, Rana TM. Small RNA-mediated regulation of iPS cell generation. EMBO J 2011; 30:823 - 34; http://dx.doi.org/10.1038/emboj.2011.2; PMID: 21285944
   PubMed Web of Science ®Google Scholar
• Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100:1234 - 42; http://dx.doi.org/10.1111/j.1349-7006.2009.01164.x; PMID: 19486339
   PubMed Web of Science ®Google Scholar
• Chuang TD, Luo X, Panda H, Chegini N. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol 2012; 26:1028 - 42; http://dx.doi.org/10.1210/me.2012-1075; PMID: 22556343
   PubMed Web of Science ®Google Scholar
• Markey MP, Bergseid J, Bosco EE, Stengel K, Xu H, Mayhew CN, et al. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene 2007; 26:6307 - 18; http://dx.doi.org/10.1038/sj.onc.1210450; PMID: 17452985
   PubMed Web of Science ®Google Scholar
• Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, et al. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis. Histopathology 2005; 46:307 - 13; http://dx.doi.org/10.1111/j.1365-2559.2005.02069.x; PMID: 15720416
   PubMed Web of Science ®Google Scholar
• Ishimi Y. A DNA helicase activity is associated with an MCM4, -6, and -7 protein complex. J Biol Chem 1997; 272:24508 - 13; http://dx.doi.org/10.1074/jbc.272.39.24508; PMID: 9305914
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010; 3:ra29; http://dx.doi.org/10.1126/scisignal.2000594; PMID: 20388916
   PubMed Web of Science ®Google Scholar
• Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136:1689 - 700; http://dx.doi.org/10.1053/j.gastro.2009.02.002; PMID: 19422085
   PubMed Web of Science ®Google Scholar
• Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, et al. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012; In press http://dx.doi.org/10.1038/onc.2012.11; PMID: 22286770
   PubMed Web of Science ®Google Scholar
• Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28:2167 - 74; http://dx.doi.org/10.1128/MCB.01977-07; PMID: 18212054
   PubMed Web of Science ®Google Scholar
• Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007; 8:R214; http://dx.doi.org/10.1186/gb-2007-8-10-r214; PMID: 17922911
   PubMed Web of Science ®Google Scholar
• Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, et al. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res 2008; 68:5104 - 12; http://dx.doi.org/10.1158/0008-5472.CAN-07-5680; PMID: 18593909
   PubMed Web of Science ®Google Scholar
• Rizzi F, Belloni L, Crafa P, Lazzaretti M, Remondini D, Ferretti S, et al. A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. PLoS One 2008; 3:e3617; http://dx.doi.org/10.1371/journal.pone.0003617; PMID: 18974881
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465:1033 - 8; http://dx.doi.org/10.1038/nature09144; PMID: 20577206
   PubMed Web of Science ®Google Scholar
• Dean JL, Thangavel C, McClendon AK, Reed CA, Knudsen ES. Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene 2010; 29:4018 - 32; http://dx.doi.org/10.1038/onc.2010.154; PMID: 20473330
   PubMed Web of Science ®Google Scholar
• Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J, et al. Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis. Mol Cell Biol 2004; 24:9527 - 41; http://dx.doi.org/10.1128/MCB.24.21.9527-9541.2004; PMID: 15485920
   PubMed Web of Science ®Google Scholar
• Suzuki S, Adachi A, Hiraiwa A, Ohashi M, Ishibashi M, Kiyono T. Cloning and characterization of human MCM7 promoter. Gene 1998; 216:85 - 91; http://dx.doi.org/10.1016/S0378-1119(98)00323-0; PMID: 9714754
   PubMed Web of Science ®Google Scholar
• Thangavel C, Dean JL, Ertel A, Knudsen KE, Aldaz CM, Witkiewicz AK, et al. Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. Endocr Relat Cancer 2011; 18:333 - 45; http://dx.doi.org/10.1530/ERC-10-0262; PMID: 21367843
   PubMed Web of Science ®Google Scholar
• Kolachala VL, Wang L, Obertone TS, Prasad M, Yan Y, Dalmasso G, et al. Adenosine 2B receptor expression is post-transcriptionally regulated by microRNA. J Biol Chem 2010; 285:18184 - 90; http://dx.doi.org/10.1074/jbc.M109.066555; PMID: 20388705
   PubMed Web of Science ®Google Scholar
• Thangavel C, Boopathi E, Shapiro BH. Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men. Endocrinology 2011; 152:4813 - 24; http://dx.doi.org/10.1210/en.2011-1274; PMID: 21952236
   PubMed Web of Science ®Google Scholar
• Djuranovic S, Zinchenko MK, Hur JK, Nahvi A, Brunelle JL, Rogers EJ, et al. Allosteric regulation of Argonaute proteins by miRNAs. Nat Struct Mol Biol 2010; 17:144 - 50; http://dx.doi.org/10.1038/nsmb.1736; PMID: 20062058
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108:5003 - 8; http://dx.doi.org/10.1073/pnas.1019055108; PMID: 21383194
   PubMed Web of Science ®Google Scholar
• Chiodelli P, Urbinati C, Mitola S, Tanghetti E, Rusnati M. Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation. J Biol Chem 2012; 287:20456 - 66; http://dx.doi.org/10.1074/jbc.M111.337139; PMID: 22528484
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Rivadeneira DB, Ertel A, Kline J, Hyslop T, Schwartz GF, et al. Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am J Pathol 2011; 179:1171 - 8; http://dx.doi.org/10.1016/j.ajpath.2011.05.043; PMID: 21756866
   PubMed Web of Science ®Google Scholar